ARM Rallies 15% to 256.59, Targeting 300 Resistance With Shorts Still Elevated
Arm's move reflects broadening chip-sector momentum beyond NVDA, with the royalty stream on Nvidia's guided 20B Vera CPU revenue adding a tangible earnings catalyst. At 100x forward P/E versus Nvidia's 25x, a squeeze through 300 would test how far valuation extension can run across the IXIC.
RKey facts
- Arm rallied 15% to 256.59, targeting 300-level technical resistance
- AMD up 8% intraday on semiconductor strength and rotation from Nvidia
- Arm trades at 100x forward P/E vs. Nvidia's 25x; valuation stretched
- Nvidia guides 20B Vera CPU revenue; Arm captures 2-5% via royalties
- Short positioning in Arm elevated, creating squeeze risk toward 300
What's happening
Arm's 15% rally to 256.59 is not just a stock move; it signals that chip-sector momentumThe empirical fact that winners keep winning over the medium term. is broadening beyond Nvidia. The stock is now targeting the 300 level, where analysts see a formidable technical resistance. What matters is that short positioning remains elevated, meaning that a burst through 300 would trigger a squeeze that could accelerate the move higher. This is the mirror image of Nvidia's reign as the only mega-cap AI winner: the supply chain is now catching up.
The context is critical. Nvidia's Q1 guidanceCompany-issued forecasts of future financial performance. of 91 billion for Q2, excluding China, has convinced traders that AI hyperscaler capex will sustain through 2026 and beyond. This belief extends to Arm, which derives revenue from licensing fees and royalties on every Nvidia-compatible processor sold. Nvidia guides for 20 billion in standalone Vera CPU revenue, and while Arm's take-rate is modest (2-5% via royalties), the absolute dollars add up. Analysts are now re-rating Arm at a forward P/E of 100x, versus Nvidia's 25x, a sign of speculative fervor that mirrors the 2018 AI hype cycle.
The broader semiconductor rally (AMD, Broadcom, etc.) reflects a rotation thesis: money is moving from single-name concentration (Nvidia) into diversified chip exposure. This is a flight-to-safety play within the tech sector, not a flight-to-safety out of tech. Breadth is improving. Short squeezes, if they materialize, could further accelerate the move, but at some point, valuation gravity will reassert itself.
The risk is that traders are extrapolating Nvidia's success into the entire supply chain, missing the fact that Arm's licensing model lacks the operating leverage of Nvidia's data center juggernaut. If AI capex slows, Arm is the first to suffer, not the last. The 300 level will be a key test of conviction.
What to watch next
- 01Arm break above 300 level; watch for short squeezeRapid price rise forcing short sellers to buy back, accelerating the move. acceleration
- 02Nvidia customer inventory reports from cloud providers next quarter
- 03Taiwan Semiconductor (TSMC) capex guidanceCompany-issued forecasts of future financial performance. and utilization rates
- CointelegraphCrypto Biz: Institutions tighten their grip on Bitcoin, AI and prediction markets
Institutional crypto adoption accelerates as Tether expands Bitcoin holdings, miners pivot to AI and Polymarket joins Nasdaq amid $1 billion fund outflows.
13m ago - PR Newswire FinancialMedpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, May 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Medpace Holdings, Inc. ("Medpace" or the "Company") (NASDAQ: MEDP). IF YOU SUFFERED A LOSS ON YOUR...
15m ago - PR Newswire FinancialAtara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, May 22, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ: ATRA). IF YOU SUFFERED A LOSS ON YOUR...
15m ago - Nikkei AsiaKawasaki Heavy to partner with Nvidia on physical AI, open US robot center35m ago
- Nikkei AsiaKOSPI jumps 8.4% on Samsung strike suspension, Nvidia results35m ago
- Nikkei AsiaEditor's Choice: Nvidia and Asia's three chip giants cash in on AI gold rush35m ago
- Yahoo FinanceCerebras Systems' Chips May Be 15X Faster Than Some of Nvidia's Blackwell Models, but Nvidia Has 2 Distinct Advantages41m ago
- Yahoo FinanceNvidia Slumps Amid 'Parabolic' Data Center Demand, Earnings Beat; Is Nvidia A Buy Now?49m ago
Related coverage
- ARM Rallies 15% to $256.59 on Vera Royalties Worth at Most $150M AnnuallyTech & AI··0 mentions
- NVDA $91B Guidance Confirms AI Capex Cycle, ARM Gains 15% on RepricingTech & AI··0 mentions
- ARM Rallies 15% to $256.59 on Nvidia Vera Royalty Logic, Valuation Gap WidensTech & AI··0 mentions
- NVDA Posts $81.6B Quarter and Guides $91B, Raising the S&P 500 Concentration StakesTech & AI··0 mentions
More about $ARM
- ARM Rallies 15% to $256.59 on Vera Royalties Worth at Most $150M Annually·Tech & AI
- ARM Surges 15% to $256.59 at 100x Forward P/E on NVDA Vera Royalty Expectations·Tech & AI
- NVDA's $91B Guidance Drives 40-Plus Percent S&P 500 Return Concentration·Tech & AI
- ARM Surges 15% to $256.59 on Nvidia Vera CPU Royalty Math Worth Up to $1B·Tech & AI
- NVDA $91B Guidance Confirms AI Capex Cycle, ARM Gains 15% on Repricing·Tech & AI
Live coverage of the AI semiconductor cycle — NVDA, AVGO, AMD, ASML, memory demand, capex run rates and overbought signals.